** Shares of Chinese pharmaceutical and medical devices
distributor Sinopharm Group Co Ltd 1099.HK rise as much as 3%
to HK$16.30, their biggest intraday pct gain since May 20
** Drugmaker Merck & Co MRK.N said on Wednesday that it
has agreed to allow Sinopharm to distribute and import its
COVID-19 antiviral molnupiravir in China, if the drug is
approved for use there urn:newsml:reuters.com:*:nL1N30Z2R6
** Merck said it will allow China National Biotec Group, an
affiliate of Sinopharm, to make the drug in China and has agreed
to transfer technology to help with that production
** The Hang Seng Commerce & Industry Index .HSNC and the
healthcare index .HSCIH rise 1.4% each
** The Hang Seng Composite Index .HSCI climbs 0.9% and the
Hang Seng Index .HSI rises 1.2%
** As of last close, Sinopharm stock down 6.7% this year
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))